These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11789448)

  • 1. [Banks of biological samples should be used with respect to donors].
    Tormo MJ
    Epidemiol Prev; 2001; 25(4-5):146-7. PubMed ID: 11789448
    [No Abstract]   [Full Text] [Related]  

  • 2. Combining efficiency and concerns about integrity when using human biobanks.
    Hansson MG
    Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):520-32. PubMed ID: 16980192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biological specimen banks: epidemiological tools and scientific enterprises].
    Muti P
    Epidemiol Prev; 2003; 27(2):121-5. PubMed ID: 12848025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biobanks: state of the art in Italy, Europe and the US.
    Parodi B; Truini M
    Pathologica; 2008 Apr; 100(2):55-66. PubMed ID: 18792521
    [No Abstract]   [Full Text] [Related]  

  • 5. Tissue banks: an opportunity for pathologists.
    Nappi O; Ruco L
    Pathologica; 2008 Apr; 100(2):43-8. PubMed ID: 18792519
    [No Abstract]   [Full Text] [Related]  

  • 6. Biobanks: instrumentation, personnel and cost analysis.
    Barbareschi M; Cotrupi S; Guarrera GM
    Pathologica; 2008 Apr; 100(2):139-48. PubMed ID: 18792526
    [No Abstract]   [Full Text] [Related]  

  • 7. [Centers of biological resources in health care facilities].
    Bourel M; Ardaillou R
    Bull Acad Natl Med; 2002; 186(8):1551-64. PubMed ID: 12669369
    [No Abstract]   [Full Text] [Related]  

  • 8. Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers.
    Pukkala E; Andersen A; Berglund G; Gislefoss R; Gudnason V; Hallmans G; Jellum E; Jousilahti P; Knekt P; Koskela P; Kyyrönen PP; Lenner P; Luostarinen T; Löve A; Ogmundsdóttir H; Stattin P; Tenkanen L; Tryggvadóttir L; Virtamo J; Wadell G; Widell A; Lehtinen M; Dillner J
    Acta Oncol; 2007; 46(3):286-307. PubMed ID: 17450464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethical framework for previously collected biobank samples.
    Helgesson G; Dillner J; Carlson J; Bartram CR; Hansson MG
    Nat Biotechnol; 2007 Sep; 25(9):973-6. PubMed ID: 17846619
    [No Abstract]   [Full Text] [Related]  

  • 10. [For better health research: biological banks].
    Kaulen H
    Dtsch Med Wochenschr; 2003 Dec; 128(50):2629-30. PubMed ID: 14702963
    [No Abstract]   [Full Text] [Related]  

  • 11. One-time general consent for research on biological samples: is it compatible with the health insurance portability and accountability act?
    Wendler D
    Arch Intern Med; 2006 Jul; 166(14):1449-52. PubMed ID: 16864754
    [No Abstract]   [Full Text] [Related]  

  • 12. Legal aspects of biobanks.
    Macilotti M; Izzo U; Pascuzzi G; Barbareschi M
    Pathologica; 2008 Apr; 100(2):86-115. PubMed ID: 18792524
    [No Abstract]   [Full Text] [Related]  

  • 13. So what are we going to do about research using clinical information and samples?
    Clayton EW
    IRB; 2004; 26(6):14-5. PubMed ID: 15658018
    [No Abstract]   [Full Text] [Related]  

  • 14. Reliability of measurements of serum alanine transaminase activity and the impact on the cut-off value for the selection of blood donors.
    Morisco F; Rosmini F
    Haematologica; 2002 May; 87(5):559-60. PubMed ID: 12010677
    [No Abstract]   [Full Text] [Related]  

  • 15. [Preliminary report on the presence of acetylsalicylic acid in blood banks].
    Furlan G; Risaliti A; Giorgini A; Zacchi T
    Boll Ist Sieroter Milan; 1981; 60(4):328-30. PubMed ID: 7326105
    [No Abstract]   [Full Text] [Related]  

  • 16. Blood rhetoric exceeds supply. As observers gauge severity of shortage crisis and blood suppliers grasp for solutions, blood banks try to motivate confused donors.
    Becker C
    Mod Healthc; 2002 Jul; 32(27):6-7, 16, 1. PubMed ID: 12141174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bypassing consent for research on biological material.
    Hofmann BM
    Nat Biotechnol; 2008 Sep; 26(9):979-80; author reply 980-1. PubMed ID: 18779801
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-Brucella antibody seroprevalence in blood donors for therapeutic ends at three blood banks of the Mexican Institute of Social Security].
    Torres-Padilla JC; López-Merino A; García-Escamilla RM; Gutiérrez-García JN
    Gac Med Mex; 2004; 140(4):391-8. PubMed ID: 15456149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [What are the requirements for establishing a biological specimen bank?].
    Tjønneland AM; Olsen A
    Ugeskr Laeger; 2003 Apr; 165(16):1686-8. PubMed ID: 12756832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ethical aspects of biological sample banks].
    Cambon-Thomsen A; Rial-Sebbag E
    Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 2):101-10. PubMed ID: 12684566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.